CORMEDIX INC. - COMMON

Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections

15 Jun 2023 08:30:00 By Nasdaq GlobeNewswire

Cormedix Inc. To Present At The Jefferies Healthcare Conference

30 May 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Resubmission of New Drug Application for DefenCath

16 May 2023 07:00:01 By Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

15 May 2023 16:05:01 By Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023

08 May 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

03 May 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath

01 May 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Regulatory, Manufacturing and Reimbursement Updates

26 Apr 2023 08:30:00 By Nasdaq GlobeNewswire

Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors

17 Apr 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

30 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023

21 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Regulatory and Manufacturing Updates

02 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Promotions in Commercial and Tech Ops

17 Jan 2023 08:30:00 By Nasdaq GlobeNewswire

Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections

06 Dec 2022 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update

10 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath

07 Nov 2022 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10

02 Nov 2022 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference

20 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference

07 Sep 2022 08:30:01 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

11 Aug 2022 07:30:01 By Nasdaq GlobeNewswire